Previous studies showed that upregulation of AGAP2-AS1 promoted cell proliferation and metastasis in pancreatic cancer, glioma, gastric cancer and non-small-cell lung cancer 6,7,21,22. Here, AGAP2 is linked to non-small cell lung carcinoma.